Jeff Haxer
Associé,
Merger & Acquisition (M&A) expert in our Healthcare practice, including pharma, medical devices and insurance
À propos de Jeff
Expertise
Highlights
- Expert in our M&A, Supply Chain Management and Healthcare practices
- Leader of dozens of corporate and PE due diligence assessments, multiple post-merger integration assignments and several complex separations/carve-outs
Jeff Haxer is an expert in our Mergers & Acquisitions, Supply Chain Management and Healthcare practiceso. He leads our global Divestitures solution and is a member of our M&A and Divestitures leadership team.
He advises clients across a range of industries, including pharmaceuticals (small and large molecule), medical devices, automotive, insurance, distribution (cold chain and non-cold chain), packaging (rigid and flexible) and agriculture.
Jeff has led more than 35 corporate and PE due diligence assessments, multiple post-merger integration assignments and several complex separations and carve-outs. His supply chain performance improvement experience includes in-plant complexity reduction work, installation of S&OP and forecasting/inventory planning processes, inventory optimization and network optimization.
Prior to joining the firm, Jeff worked in other consulting roles, helping clients improve operations across the automotive and pharmaceutical distribution industries.
Jeff earned an MBA from the MIT Sloan School of Management and a BBA, with honors, from the University of Michigan.
Recent Insights
- “Investor Relations: How to Get the Valuation You Deserve ,” Webinar, 31 mars 2022
- “Healthcare Corporate M&A: Rebounding from the Pandemic,” Rapport, 15 mars 2022
- “Healthcare Private Equity in North America: Macro Trends Broaden Investment Opportunities ,” Rapport, 15 mars 2022
- “Healthcare M&A,” M&A Report, 8 février 2022, Rapport
- “Healthcare M&A 2021: Trends in Medtech,” Video, 26 août 2021